Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Vaccines
New research in the area of cancer vaccines detailed
July 7th, 2005
Investigators in the United States, Denmark and Australia have published new cancer vaccines data. Study 1: Researchers describe the early role of CD4+ Th1 cells and antibodies in HER-2 adenovirus vaccine protection against autochthonous mammary carcinomas in a recent issue of the Journal of Immunology. According to a study from the United States, "HER-2 is an oncogenic tumor-associated antigen that is overexpressed in several human tumors including breast and ovarian cancer. The efficacy and mechanism of a HER-2-expressing recombinant adenoviral vaccine to protect against tumorigenesis was examined using HER-2 transgenic...
Source: Women's Health Weekly (2005-07-07)
|
